Innovation & Development

SouthViews No. 160, 19 January 2018

Heading off Global Action on Access to Medicines in 2018

By Dr. Jorge Bermudez and Dr. Viroj Tangcharoensathien

At the dawn of 2018, political and health leaders must seize the growing momentum and opportunities to tackle the protracted challenges of access to medicines that undermine efforts to save lives and improve health as committed under the Agenda 2030 SDG by all UN member states. (more…)

SouthViews No. 159, 3 January 2018

Critical issues to watch in 2018

By Martin Khor

There are several key social and environmental issues to watch out for in 2018 as they are close to reaching a tipping point, says this preview of the new year by the South Centre’s Executive Director Martin Khor. (more…)

Statement, December 2017

South Centre Statement at the 27th Session of the World Intellectual Property Organization (WIPO) Standing Committee on the Law of Patents

As this year’s work in the WIPO substantive committees will end with the conclusion of the 27th session of the Standing Committee on the Law of Patents (SCP), we are reminded that next year will mark the tenth anniversary since the SCP had reconvened in 2008 with a focus on developing a balanced work programme on issues relating to the law of patents to also address development and public policy questions that arise in the context of the patent system. The work of the SCP, in this sense, is integral to advancing the WIPO Development Agenda.

(more…)

SouthViews No. 157, 9 December 2017

Action Needed to Avoid the End of Modern Medicine

By Martin Khor

As global health leaders warn that antibiotic resistance is leading to the end of modern medicine, the World Health Organization (WHO) issues guidelines to prohibit or restrict using antibiotics to feed animals reared for their meat. Urgent coordinated actions are needed to avoid the end of modern medicine. The author Martin Khor is the Executive Director of the South Centre. This article was also published by Inter Press Service (IPS) (more…)

Statement, November 2017

Statement by the South Centre on EU-MERCOSUR Trade Negotiations

EU-MERCOSUR Trade Negotiations must not impose TRIPS Plus provisions on Protection and Enforcement of Intellectual Property Rights

(more…)

Research Paper 82, November 2017

The International Debate on Generic Medicines of Biological Origin

The debate on generic medicines is not new. What makes it different today is that attacks levelled against biological products are couched in ever more “technical” and abstruse language that confuses even the World Health Organization (WHO).

(more…)

SouthViews No. 156, 26 October 2017

Intellectual Property for the TwentyFirst-Century Economy

By Joseph E. Stiglitz , Dean Baker , Arjun Jayadev

Developing countries are increasingly pushing back against the intellectual property regime foisted on them by the advanced economies over the last 30 years. They are right to do so, because what matters is not only the production of knowledge, but also that it is used in ways that put the health and wellbeing of people ahead of corporate profits. (more…)

Policy Brief 45, October 2017

The Value Added of the United Nations General Assembly High–Level Political Declaration on Antimicrobial Resistance

In September 2016, the United Nations General Assembly (UNGA) in New York held a dedicated meeting to muster strong political commitment for an effective global response to the problem of antimicrobial resistance (AMR). As a result, a High-Level Political Declaration on Antimicrobial Resistance was adopted.

(more…)